早期类风湿关节炎患者1年时HAQ评分可预测全因死亡率
该研究基于加拿大早期关节炎队列1724例早期RA患者,评估基线及1年时HAQ评分与全因死亡率的关联。随访10年记录62例死亡(3.6%),1年时HAQ评分与全因死亡率独立相关(调整后HR 1.75,95%CI 1.10-2.77),而基线HAQ评分调整后关联不显著。
要点
- 早期RA患者1年时HAQ评分越高,全因死亡风险越高(调整后HR 1.75)。
- 基线HAQ评分与死亡率的关联在调整混杂因素后不显著。
- 1年时DAS28较高也与全因死亡率显著相关。
核心结论
- 早期RA患者1年时HAQ评分和DAS28较高与全因死亡率显著相关。
研究设计与样本
- 加拿大早期关节炎队列中症状持续时间<1年、起始DMARDs治疗且基线和1年HAQ数据完整的早期RA患者。
- 共纳入1724例患者,平均年龄55岁,72%为女性,随访10年。
- 采用离散时间比例风险模型估计基线HAQ和1年HAQ与全因死亡率的粗关联和多因素调整关联。
主要发现
- 10年随访期间记录62例死亡(3.6%)。
- 死亡患者基线HAQ均值±SD为1.2±0.7,1年时为0.9±0.7;存活患者分别为1.0±0.7和0.5±0.6(P<0.001)。
- 死亡患者基线DAS28均值±SD为5.4±1.3,1年时为3.6±1.4;存活患者分别为4.9±1.4和2.8±1.4(P<0.001)。
- 基线HAQ未调整HR为1.46(95%CI 1.02-2.09),调整后HR为1.25(95%CI 0.81-1.94)。
- 1年时HAQ未调整HR为2.58(95%CI 1.78-3.72),调整后HR为1.75(95%CI 1.10-2.77)。
关键数值与推荐
- 年龄较大、男性、教育水平较低、吸烟、更多合并症、基线DAS28较高及糖皮质激素使用与死亡率相关。
临床怎么用
- 对早期RA患者应关注1年时HAQ评分,高HAQ评分提示全因死亡风险增加,可辅助风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Higher self-reported disability (high Health Assessment Questionnaire [HAQ] score) has been associated with hospitalizations and mortality in established rheumatoid arthritis (RA), but associations in early RA are unknown. METHODS: Patients with early RA (symptom duration <1 year) enrolled in the Canadian Early Arthritis Cohort who initiated disease-modifying antirheumatic drugs and had completed HAQ data at baseline and 1 year were included in the study. Discrete-time proportional hazards models were used to estimate crude and multi-adjusted associations of baseline HAQ and HAQ at 1 year with all-cause mortality in each year of follow-up. RESULTS: A total of 1,724 patients with early RA were included. The mean age was 55 years, and 72% were women. Over 10 years, 62 deaths (3.6%) were recorded. Deceased patients had higher HAQ scores at baseline (mean ± SD 1.2 ± 0.7) and at 1 year (0.9 ± 0.7) than living patients (1.0 ± 0.7 and 0.5 ± 0.6, respectively; P < 0.001). Disease Activity Score in 28 joints (DAS28) was higher in deceased versus living patients at baseline (mean ± SD 5.4 ± 1.3 versus 4.9 ± 1.4) and at 1 year (mean ± SD 3.6 ± 1.4 versus 2.8 ± 1.4) (P < 0.001). Older age, male sex, lower education level, smoking, more comorbidities, higher baseline DAS28, and glucocorticoid use were associated with mortality. Contrary to HAQ score at baseline, the association between all-cause mortality and HAQ score at 1 year remained significant even after adjustment for confounders. For baseline HAQ score, the unadjusted hazard ratio (HR) was 1.46 (95% confidence interval [95% CI] 1.02-2.09), and the adjusted HR was 1.25 (95% CI 0.81-1.94). For HAQ score at 1 year, the unadjusted HR was 2.58 (95% CI 1.78-3.72), and the adjusted HR was 1.75 (95% CI 1.10-2.77). CONCLUSION: Our findings indicate that higher HAQ score and DAS28 at 1 year are significantly associated with all-cause mortality in a large early RA cohort.
引用
- Fatima S, Schieir O, Valois MF, et al. Health Assessment Questionnaire at One Year Predicts All-Cause Mortality in Patients With Early Rheumatoid Arthritis. Arthritis Rheumatol. 2020. PMID: 32892510. doi:10.1002/art.41513
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。